Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2019-06-04 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
独立董事关于公司第三届董事会第三十六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on specific board meeting matters related to stock repurchase and stock option cancellations. It references compliance with regulatory guidelines and company rules but does not contain financial statements or detailed financial data. The document is short (705 characters) and focuses on board-related decisions rather than full financial reporting. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management.
2019-06-04 Chinese
国浩律师（深圳）事务所关于公司注销部分股票期权之法律意见书
Legal Proceedings Report Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the cancellation of certain stock options of a company. It references specific stock option incentive plans, approvals by the company's board and shareholders, and compliance with relevant laws and regulations. The document is a standalone legal opinion related to a corporate action (stock option cancellation) rather than a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data, nor is it a regulatory announcement or a proxy solicitation. The document is a legal proceeding related report, specifically a legal opinion on stock option cancellation, which fits best under Legal Proceedings Report (LTR).
2019-06-04 Chinese
关于召开2019年第二次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about the convening of the 2019 second extraordinary general meeting of shareholders for the company. It includes information about the meeting date, voting procedures (including online voting), agenda items to be discussed and voted on (such as stock repurchase and amendment of the company charter), registration details, and proxy authorization forms. There are no financial statements or management discussion of financial results. The document is not a report itself but a formal announcement and invitation to shareholders to attend and vote at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings.
2019-06-04 Chinese
第三届监事会第二十七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 27th meeting of the third Supervisory Board of the company. It details decisions regarding the repurchase and cancellation of restricted stocks and stock options due to employee departures and performance issues. The document includes voting results and references to prior announcements on the official disclosure website. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement of board-level decisions related to stock incentives, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Board/Management Information (MANG) which typically covers changes in board or senior management personnel, or Share Issue/Capital Change (SHA) which would cover new share issues or stock splits rather than repurchase/cancellation of restricted stock and options. The document length is short (1448 characters), and it is a formal announcement of resolutions rather than a full report or financial disclosure.
2019-06-04 Chinese
关于部分董事减持计划实施完毕的公告
Director's Dealing Classification · 100% confidence The document is a formal announcement from a company regarding the completion of a share reduction plan by a director (曾凯). It details the number of shares reduced, the method of reduction, dates, and compliance with relevant securities laws and regulations. The document does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is a notification about a director's personal share transactions (share reduction). Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on this topic, confirming it is not a broader report or announcement type.
2019-05-22 Chinese
关于原5%以上股东减持计划实施结果暨减持计划到期公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the implementation results of a shareholding reduction plan by a shareholder holding more than 5% of the company's shares. It details the number of shares reduced, the methods, dates, and prices, as well as compliance with relevant securities laws and regulations. This type of document is a notification about changes in major shareholdings, specifically the reduction of shares by a significant shareholder. It is not a financial report, earnings release, or management discussion, nor is it a proxy or voting announcement. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding changes, confirming this classification with high confidence.
2019-05-15 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.